Chiesi Wins EU Approval for Pediatric LOJUXTA Use
PARMA, Italy, June 5, 2026 Chiesi Global Rare Diseases has announced a major regulatory milestone following the European Commission’s...
European Commission Approval
Advertisement
Servier Acquires Edgewise Muscular Dystrophy Business for $2.65B
SURESNES, France, June 1, 2026 Servier has announced a landmark agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in...
AbbVie Secures EU Approval for AQUIPTA as Acute Migraine Treatment
NORTH CHICAGO, Ill., June 2, 2026 AbbVie has announced that the European Commission (EC) has approved AQUIPTA® (atogepant) for...
Lupin Wins Tentative FDA Approval for COPD Inhalation Therapy Revefenacin
MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...
Sandoz Secures EC Approval for Bysumlog and Dazparda Diabetes Biosimilars
BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...
Advertisements
Bristol Myers Squibb Secures EU Approval for Sotyktu in Psoriatic Arthritis
PRINCETON, N.J., May 11, 2026 Bristol Myers Squibb announced that the European Commission has approved Sotyktu (deucravacitinib) for the...
Henlius and Organon Secure EU Approval for POHERDY®
SHANGHAI, China & JERSEY CITY, N.J., April 29, 2026 Shanghai Henlius Biotech, Inc. and Organon have announced that the...
Merck ENFLONSIA Approved in EU for Infant RSV Protection
RAHWAY, N.J., April 17, 2026 Merck & Co., Inc. announced that the European Commission (EC) has approved ENFLONSIA™ (clesrovimab),...
Merck Wins EU Approval for KEYTRUDA Combo in Ovarian Cancer
RAHWAY, N.J., April 2, 2026 Merck (MSD) has secured a major regulatory milestone as the European Commission approves KEYTRUDA®...
Incyte’s Zynyz Approved in EU for Advanced Anal Cancer
March 06, 2026 — Wilmington, Delaware, USA Global biopharmaceutical innovator Incyte has announced that the European Commission has approved...
Advertisement
